ANIP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ANI Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 83.05 USD 0.33% Market Closed

Market Cap: $1.9B

	ANI Pharmaceuticals Inc NASDAQ:ANIP	US
V	Verizon Communications Inc DUS:BAC	US
X	XOMA Corp LSE:0M26	US

Profitability Summary

ANI Pharmaceuticals Inc's profitability score is 57/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

63% > 61%

Healthy Operating Margin

13%

Low 3Y Average Operating Margin

Operating Margin is Increasing

6% > 13%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-2% > 8%

Exceptional Free Cash Flow Margin

19%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

View All

Hide

Collapse

57 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.